A single-arm, multicenter, open-label phase 2 study of lapatinib as the second-line treatment of patients with locally advanced or metastatic transitional cell carcinoma

Authors :: Wulfing, Christian
Machiels, Jean-Pascal H.
Richel, Dirk J.
Grimm, Marc-Oliver
Treiber, Uwe
De Groot, Marco R.
Beuzeboc, Philippe
Parikh, Roma
Petavy, Frank
El-Hariry, Iman A.
Source :: Cancer. July 1, 2009, Vol. 115 Issue 13, p2881, 10 p.
Publication Year :: 2009

Subjects :: Adenocarcinoma -- Care and treatment
Adenocarcinoma -- Patient outcomes
Adenocarcinoma -- Research
Bladder cancer -- Care and treatment
Bladder cancer -- Patient outcomes
Bladder cancer -- Research
Health

Tools